Cargando…
How long do new medicines take to reach Canadian patients after companies file a submission: A cohort study
INTRODUCTION: Studies of the delay between when companies file a New Drug Submission (NDS) and when drugs reach Canadian patients typically focus on the time in the regulatory review process and do not analyze the time between when approval is granted and the drug is available for purchase (company...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605702/ https://www.ncbi.nlm.nih.gov/pubmed/33137156 http://dx.doi.org/10.1371/journal.pone.0240966 |